Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8153289rdf:typepubmed:Citationlld:pubmed
pubmed-article:8153289lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:8153289lifeskim:mentionsumls-concept:C0151744lld:lifeskim
pubmed-article:8153289lifeskim:mentionsumls-concept:C0020459lld:lifeskim
pubmed-article:8153289lifeskim:mentionsumls-concept:C0080310lld:lifeskim
pubmed-article:8153289pubmed:issue2lld:pubmed
pubmed-article:8153289pubmed:dateCreated1994-5-12lld:pubmed
pubmed-article:8153289pubmed:abstractTextElevated circulating insulin levels have been reported in ischaemic heart disease, and may be of aetiological importance. Previous studies have not considered the potential influence of heart failure or of previous myocardial infarction, as opposed to stable angina. We therefore measured the insulin response to a 75 g oral glucose tolerance test in five groups with normal glucose tolerance, comparing normal male controls to men with chronic stable angina, men with recent myocardial infarction (two groups, 3 weeks and 3 months post infarction), and men with chronic severe heart failure. Only patients with chronic heart failure had fasting hyperinsulinaemia, probably reflecting associated neuroendocrine abnormalities. Stimulated hyperinsulinaemia was present in all patient groups, but was less pronounced and of shorter duration in patients with angina. At 120 min, only patients with heart failure or previous myocardial infarction were hyperinsulinaemic. The degree of stimulated hyperinsulinaemia was not influenced by the presence of heart failure or by the length of time from infarction. Hyperinsulinaemia is associated with impaired peripheral muscle glucose uptake and metabolism, and might contribute to muscular fatigue on exertion in patients with previous myocardial infarction or heart failure.lld:pubmed
pubmed-article:8153289pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8153289pubmed:languageenglld:pubmed
pubmed-article:8153289pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8153289pubmed:citationSubsetIMlld:pubmed
pubmed-article:8153289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8153289pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8153289pubmed:statusMEDLINElld:pubmed
pubmed-article:8153289pubmed:monthFeblld:pubmed
pubmed-article:8153289pubmed:issn0033-5622lld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:AlbertiK GKGlld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:KEYYlld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:WrightR ARAlld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:SimpsonCClld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:FlintLLlld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:CHOWF HFHlld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:FlapanA DADlld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:StenhouseFFlld:pubmed
pubmed-article:8153289pubmed:authorpubmed-author:ReimersmaR...lld:pubmed
pubmed-article:8153289pubmed:issnTypePrintlld:pubmed
pubmed-article:8153289pubmed:volume87lld:pubmed
pubmed-article:8153289pubmed:ownerNLMlld:pubmed
pubmed-article:8153289pubmed:authorsCompleteYlld:pubmed
pubmed-article:8153289pubmed:pagination131-8lld:pubmed
pubmed-article:8153289pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:meshHeadingpubmed-meshheading:8153289-...lld:pubmed
pubmed-article:8153289pubmed:year1994lld:pubmed
pubmed-article:8153289pubmed:articleTitleHyperinsulinaemia in ischaemic heart disease: the importance of myocardial infarction and left ventricular function.lld:pubmed
pubmed-article:8153289pubmed:affiliationCardiovascular Research Unit, University of Edinburgh, UK.lld:pubmed
pubmed-article:8153289pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8153289pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8153289lld:pubmed